Literature DB >> 24535650

A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression.

D Rades1, A Weber, T Bartscht, A Bajrovic, J H Karstens, S E Schild.   

Abstract

BACKGROUND AND
PURPOSE: This study aimed to identify a potential association of the number of involved extraspinal organs with the survival of patients with metastatic spinal cord compression (MSCC) from renal cell carcinoma. PATIENTS AND METHODS: Data of 69 patients irradiated for MSCC from renal cell carcinoma were retrospectively evaluated for survival. The prognostic value of the number of involved extraspinal organs and eight additional factors were investigated. These additional factors included age, gender, performance status, number of involved vertebrae, interval from cancer diagnosis to radiotherapy (RT) of MSCC, ambulatory status prior to RT, time developing motor deficits, and the fractionation regimen (30 Gy in 10 fractions vs. higher doses).
RESULTS: The 6-month survival rates for involvement of 0, 1, and ≥ 2 extraspinal organs were 93, 57, and 21%, respectively (p < 0.001). In the multivariate analysis, the number of involved extraspinal organs maintained significance (risk ratio 2.65; 95% confidence interval 1.64-4.52; p < 0.001). The interval from cancer diagnosis to RT of MSCC (p = 0.013) and ambulatory status prior to RT (p = 0.002) were also independent predictors of survival.
CONCLUSION: The number of involved extraspinal organs is a new prognostic factor of survival in patients with MSCC from renal cell carcinoma and should be considered in future clinical trials.

Entities:  

Mesh:

Year:  2014        PMID: 24535650     DOI: 10.1007/s00066-014-0616-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.

Authors:  Dirk Rades; Marisa Lange; Theo Veninga; Lukas J A Stalpers; Amira Bajrovic; Irenaeus A Adamietz; Volker Rudat; Steven E Schild
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.

Authors:  Dirk Rades; Stefan Huttenlocher; Amira Bajrovic; Johann H Karstens; Irenaeus A Adamietz; Nadja Kazic; Volker Rudat; Steven E Schild
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

3.  Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience.

Authors:  Flavio Tancioni; Piera Navarria; Federico Pessina; Luca Attuati; Pietro Mancosu; Marco Alloisio; Marta Scorsetti; Armando Santoro; Riccardo Rodriguez Y Baena
Journal:  Eur Spine J       Date:  2012-03-10       Impact factor: 3.134

Review 4.  Malignant spinal-cord compression.

Authors:  Dheerendra Prasad; David Schiff
Journal:  Lancet Oncol       Date:  2005-01       Impact factor: 41.316

5.  Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Authors:  D Rades; S Douglas; T Veninga; A Bajrovic; L J A Stalpers; P J Hoskin; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-25       Impact factor: 3.621

6.  Metastatic spinal cord compression in patients with cancer of unknown primary. Estimating the survival prognosis with a validated score.

Authors:  S Douglas; S E Schild; D Rades
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

7.  Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?

Authors:  D Rades; S Huttenlocher; J N Evers; A Bajrovic; J H Karstens; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

8.  Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Authors:  Dirk Rades; Lukas J A Stalpers; Theo Veninga; Rainer Schulte; Peter J Hoskin; Nermina Obralic; Amira Bajrovic; Volker Rudat; Rudolf Schwarz; Maarten C Hulshof; Philip Poortmans; Steven E Schild
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

9.  Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.

Authors:  Dirk Rades; Jochen Walz; Lukas J A Stalpers; Theo Veninga; Rainer Schulte; Nermina Obralic; Ingeborg Wildfang; Rita Engenhart-Cabilic; Peter J Hoskin; Steven E Schild
Journal:  Eur Urol       Date:  2005-12-19       Impact factor: 20.096

10.  Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.

Authors:  D Rades; S Douglas; S Huttenlocher; T Veninga; A Bajrovic; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-11-01       Impact factor: 3.621

View more
  1 in total

1.  Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.

Authors:  Dorota Lubgan; Anke Ziegaus; Sabine Semrau; Ulrike Lambrecht; Sebastian Lettmaier; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2014-11-14       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.